About Sterling Pharma Solutions
Sterling Pharma Solutions is a company based in Dudley (United Kingdom) founded in 2016 was acquired by GHO Capital Partners in February 2019.. Sterling Pharma Solutions has completed 3 acquisitions, including ADC Biotechnology, CiVentiChem and NewChem Technologies. Sterling Pharma Solutions offers products and services including API Development, API Manufacturing, ADC Development, Peptide Manufacturing, and Analytical Services. Sterling Pharma Solutions operates in a competitive market with competitors including Laurus Labs, Provepharm Life Solutions, Symbiotec, Jubilant Pharma and SeQuent, among others.
- Headquarter Dudley, United Kingdom
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sterling Pharma Solutions Limited
- Date of Incorporation 16 Feb, 2006
- Jurisdiction NORTHUMBERLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Partners Group
& 1 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
ADC Biotechnology
& 2 more
-
Acquired by
GHO Capital Partners
(Feb 28, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sterling Pharma Solutions
Sterling Pharma Solutions offers a comprehensive portfolio of products and services, including API Development, API Manufacturing, ADC Development, Peptide Manufacturing, and Analytical Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Services for API route scouting and process optimization.
cGMP production of APIs including high-potency and hazardous compounds.
Support for ADC discovery, development, and clinical manufacturing.
Analysis, purification, and production of novel peptides.
Techniques like mass spectrometry for drug molecule evaluation.
Unlock access to complete
Software Development Team
44 people
Product Management Team
22 people
Leadership Team
16 people
Senior Team
15 people
Human Resources and Administration
13 people
Sales and Marketing
12 people
Process Team
8 people
Principal Team
5 people
Unlock access to complete
Funding Insights of Sterling Pharma Solutions
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Seed - Sterling Pharma Solutions | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sterling Pharma Solutions
Sterling Pharma Solutions has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Partners Group and GHO Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Specialist healthcare investment advisory services are provided by GHO Capital.
|
Founded Year | Domain | Location | |
|
Private equity funds are managed across multiple sectors globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sterling Pharma Solutions
Sterling Pharma Solutions has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include ADC Biotechnology, CiVentiChem and NewChem Technologies. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of antibody drug conjugate (ADC)
|
2010 | ||||
|
NewChem Technologies is an chemical company specializing in commercial applications for organic chemistry.
|
2002 | ||||
|
Contract research and manufacturing services are offered for pharmaceuticals.
|
1994 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Sterling Pharma Solutions
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sterling Pharma Solutions Comparisons
Competitors of Sterling Pharma Solutions
Sterling Pharma Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Provepharm Life Solutions, Symbiotec, Jubilant Pharma and SeQuent, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical and biotechnology company
|
|
| domain | founded_year | HQ Location |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| domain | founded_year | HQ Location |
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
|
|
| domain | founded_year | HQ Location |
APIs are developed and manufactured for therapeutic areas.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sterling Pharma Solutions
Frequently Asked Questions about Sterling Pharma Solutions
When was Sterling Pharma Solutions founded?
Sterling Pharma Solutions was founded in 2016 and raised its 1st funding round 7 years after it was founded.
Where is Sterling Pharma Solutions located?
Sterling Pharma Solutions is headquartered in Dudley, United Kingdom. It is registered at Dudley, West Midlands, United Kingdom.
Who is the current CEO of Sterling Pharma Solutions?
Kevin Cook is the current CEO of Sterling Pharma Solutions.
What does Sterling Pharma Solutions do?
Sterling Pharma Solutions was established in 2016 in Dudley, United Kingdom. Operations focus on the pharmaceutical sector as a contract development and manufacturing organization (CDMO). Services encompass contract development, manufacturing, and analytical support specifically for active pharmaceutical ingredients (APIs). The company is led by CEO Kevin Cook and maintains its primary location in the UK to serve global clients in the industry.
Who are the top competitors of Sterling Pharma Solutions?
Sterling Pharma Solutions's top competitors include Laurus Labs, Symbiotec and Provepharm Life Solutions.
What products or services does Sterling Pharma Solutions offer?
Sterling Pharma Solutions offers API Development, API Manufacturing, ADC Development, Peptide Manufacturing, and Analytical Services.
How many acquisitions has Sterling Pharma Solutions made?
Sterling Pharma Solutions has made 3 acquisitions, including ADC Biotechnology, CiVentiChem, and NewChem Technologies.
Who are Sterling Pharma Solutions's investors?
Sterling Pharma Solutions has 2 investors. Key investors include Partners Group, and GHO Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.